What Drove The NeuBase (NBSE) Stock Higher In Extended Trades?
After disclosing a proposal for organizational reorganization, NeuBase Therapeutics Inc. (NASDAQ: NBSE) shares increased 11.85% to $0.3029 on Friday after-hours trading. The NBSE stock lost -9.73% to close the last trading session at $0.27. What has NBSE disclosed? NeuBase (NBSE) disclosed plans to reorganize the business to concentrate on the development of its gene-editing platform. […]